Agonists of the glucocorticoid receptor, the gene product of NR3C1, a member of both the circadian clock and glial cell pathways, are approved for osteoarthritis pain relief, due to its anti-inflammatory ability. This evidence concerns the gene NR3C1 and osteoarthritis.